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de Lange syndromes
Alice Watkins1,2* , Stacey Bissell1, Jo Moss1,3, Chris Oliver1, Jill Clayton-Smith4, Lorraine Haye1, Mary Heald1 and
Alice Welham1,5
Abstract
Background: Pitt-Hopkins syndrome (PTHS) is a genetic neurodevelopmental disorder associated with intellectual
disability. Although the genetic mechanisms underlying the disorder have been identified, description of its behavioural
phenotype is in its infancy. In this study, reported behavioural and psychological characteristics of individuals with PTHS
were investigated in comparison with the reported behaviour of age-matched individuals with Angelman syndrome
(AS) and Cornelia de Lange syndrome (CdLS).
Methods: Questionnaire data were collected from parents/caregivers of individuals with PTHS (n = 24), assessing
behaviours associated with autism spectrum disorder (ASD), sociability, mood, repetitive behaviour, sensory processing,
challenging behaviours and overactivity and impulsivity. For most measures, data were compared to data for people
with AS (n = 24) and CdLS (n = 24) individually matched by adaptive ability, age and sex.
Results: Individuals with PTHS evidenced significantly higher levels of difficulties with social communication and reciprocal
social interaction than individuals with AS, with 21 of 22 participants with PTHS meeting criteria indicative of
ASD on a screening instrument. Individuals with PTHS were reported to be less sociable with familiar and unfamiliar
people than individuals with AS, but more sociable with unfamiliar people than individuals with CdLS. Data
also suggested areas of atypicality in sensory experiences. Challenging behaviours were reported frequently in
PTHS, with self-injury (70.8%) occurring at significantly higher rates than in AS (41.7%) and aggression (54.2%)
occurring at significantly higher rates than in CdLS (25%). Individuals with PTHS also evidenced lower reported mood
than individuals with AS.
Conclusions: Behaviours which may be characteristic of PTHS include those associated with ASD, including deficits in
social communication and reciprocal social interaction. High rates of aggression and self-injurious behaviour compared
to other genetic syndrome groups are of potential clinical significance and warrant further investigation. An atypical
sensory profile may also be evident in PTHS. The specific aetiology of and relationships between different behavioural
and psychological atypicalities in PTHS, and effective clinical management of these, present potential topics for future
research.
Keywords: Angelman syndrome, Autism spectrum disorder, Behavioural phenotype, Cornelia de Lange syndrome, Pitt-
Hopkins syndrome
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Background
Pitt-Hopkins syndrome (PTHS, OMIM #610954) is a
genetic neurodevelopmental disorder associated with an
abnormal expression of the basic helix-loop-helix tran-
scription factor 4 gene (TCF4) located on chromosome
18q21 (OMIM #602272). PTHS was first identified in
1978 by Pitt and Hopkins [1], who described the syn-
drome in two unrelated patients presenting with a charac-
teristic facial gestalt (comprising a squared forehead,
deep-set eyes, a wide mouth, tented upper lip, full lower
lip and a broad and/or beaked nasal bridge), developmen-
tal delay and abnormal breathing patterns [2–4]. Although
the definitive prevalence of PTHS is unknown, prevalence
estimates lie between 1 in 225,000 and 1 in 300,000 based
on the known number of affected individuals [5].
PTHS is commonly associated with intellectual disability
(ID), with severe ID identified in 100% of a cohort of 101
patients with PTHS [6]. Impaired language development
is also reported frequently, with many individuals present-
ing with absent language or speech limited to a few words
[4, 7]. Hypotonia and delays in motor development are
also prevalent, most notably delayed or absent walking,
impaired motor coordination and ataxia [6, 8].
Recent years have seen progress towards characterising
the specific behavioural characteristics associated with
PTHS, based on a number of case and cohort studies (e.g.
[4, 6, 9, 10], see [7] for a review). The first international
consensus statement about PTHS [5] draws together
current understanding of these with directions for the
diagnosis and management of PTHS. The temperament of
individuals with PTHS is often described as amiable and
happy, characterised by an “easy-going” demeanour (87%)
[5, 7] and smiling appearance (89%) [4, 6]. Indeed, it has
been noted that there are similarities with Angelman syn-
drome (AS) [4, 5], a genetic condition in which “excessive”
smiling has been established as a phenotypic behavioural
feature [7, 11, 12]. Furthermore, pathogenic variants of the
TCF4 gene have previously been identified in cases of
diagnosed AS (2%) [13], sometimes leading to delays in
diagnosis [4]. However, systematic study of social charac-
teristics using established measures with known psycho-
metric properties have been rare (although see [6, 14]),
and formal comparisons with AS are yet to be drawn.
Alongside reports of specific social characteristics, a num-
ber of behavioural traits associated with autism spectrum
disorder (ASD) are reportedly associated with PTHS. ASD
is a complex diagnostic category, defined by repetitive
behaviours/restricted interests and impairments in social
affect, which itself is defined as difficulties with communi-
cation (verbal and non-verbal) and social interaction (e.g.
[15, 16]). Consistent with possible ASD-related symptom-
atology, individuals with PTHS are reported to show
impaired social interaction and communication, stereo-
typed movements, repetitive behaviours and difficulty with
changes to daily routine [2, 5, 8, 14]. Whalen et al. [4] re-
ported an overall repetitive behaviour prevalence of 94%.
Reported stereotypies include: repetitive hand and finger
movements (48% [4], 86% [3]), arm flapping (80%) [4],
hand washing (45%) [4] and body rocking [14]. ASD
occurs with elevated frequency in a number of genetic
syndrome groups, including AS (34% [17]) and Cornelia
de Lange syndrome (CdLS, 43% [17]), and it has been
noted that having a genetic syndrome itself increases the
probability with which a person will meet diagnostic
criteria for ASD [17]. In addition, the qualitative nature of
ASD presentation may vary between genetic syndrome
groups (e.g. [18, 19]). The degree to which ASD-related
behaviours present in excess of what may be expected for
developmental level has been debated for a number of
syndrome groups (see [20]). In the case of PTHS, com-
parison with matched-ability groups with other genetic
syndromes may help elucidate the possible presence and
nature of ASD-related behaviours.
In addition to the social and repetitive elements of
ASD, sensory processing differences have been increas-
ingly foregrounded in ASD research (e.g. [21–23]), with
the DSM 5 including sensory processing factors in the
diagnostic criteria for ASD [16]. To date, the sensory pro-
cessing profile of PTHS is yet to be explicitly researched
in individuals with PTHS, and the need for further study
of this topic has been highlighted within the international
consensus statement [5].
Further areas of potential behavioural atypicality and dif-
ficulty for people with PTHS include high rates of anxiety
(81%) [4], aggression (40–50%) [2, 7, 14] and self-injurious
behaviours (e.g. pinching, hand biting, hitting oneself) [2,
6] and some reports of attention deficit hyperactivity
disorder (ADHD) [7]. Each of these behaviours has also
been associated to varying degrees with other genetic
neurodevelopmental syndromes. For example, over 70% of
people with CdLS are reported to display self-injury [24],
and a number of studies have also found high levels of
overactivity in this syndrome group (e.g. [25–27]).
The set of behaviours associated with a specific genetic
syndrome has often been referred to as a “behavioural
phenotype” [28, 29], defined as the behaviours which
occur more often in individuals with a specific syndrome
than in people without this syndrome [29, 30]. Charac-
terisation of behavioural phenotypes is aided by the use
of standardised measures suitable for people with ID
(e.g. [31–33]). In addition, comparisons with suitable
groups, including those with other genetic syndromes
also associated with ID, has been foregrounded as crucial
in the study of behavioural phenotypes [34]. To date,
much of the PTHS behavioural research is in the form
of case study or case series methodology (e.g. [10], see
[7] for a review). Where larger cohort studies have been
conducted (e.g. [4, 6, 9], see [7] for a review), a lack of
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cross-syndrome comparisons with other genetic syn-
drome groups limits interpretation.
Current study
The current study assessed reported behavioural charac-
teristics in a cohort of people diagnosed with PTHS,
using measures with established psychometric properties
and history of utility for investigation of behavioural
phenotypes of genetic neurodevelopmental syndromes
associated with ID (e.g. [18, 19, 24, 31, 35]). Measures
were included of ASD-related characteristics, sociability,
mood, repetitive behaviours, sensory processing, challen-
ging behaviours, overactivity and impulsivity.
Comparisons were made with age- and ability-matched
participants from two other genetic syndrome groups: AS
and CdLS. Selection of these two groups for comparison
was based on a number of factors. First, both AS and
CdLS are associated with ID which may be profound [12,
25], potentially increasing the likelihood of highlighting
behavioural features of PTHS which are not solely related
to ID or to having a genetic syndrome per se. In addition,
the behavioural phenotypes of AS and CdLS are both rela-
tively well established (e.g. [12, 25, 36–41]), allowing
appropriate contextualisation of data for PTHS. These
phenotypes are summarised, alongside genetic informa-
tion and information about physical characteristics, in
Table 1. AS and CdLS are also divergent on some behav-
ioural aspects, thus providing significant points of con-
trast. For example, both CdLS and AS are frequently
associated with ASD characteristics [17], but the specific
profiles of ASD-related behaviours differ. For instance, in
relation to behaviour in social contexts, positive affect
during social interactions is often reported in AS alongside
impairments in social affect contributing to meeting diag-
nostic criteria for ASD [47]. In CdLS, impaired communi-
cation and social interaction skills are prominent [19],
with difficulties putatively related at least in part to high
levels of social anxiety [48]. As in CdLS, individuals with
PTHS are reported to show impaired social interaction [5,
6, 14], although systematic study of this is lacking. How-
ever, the “happy and amiable” demeanour frequently
reported in PTHS appears to overlap with the phenotypic
smiling and laughter reported of AS [7, 11, 12]. CdLS and
AS also differ notably in associated mood, poor mood and
high anxiety [25, 49] (social anxiety in particular) [50, 51]
associated with CdLS and elevated mood associated with
AS [12]. Both AS and CdLS are associated with challen-
ging behaviour, but AS is associated with higher rates of
aggression compared to CdLS (73% > 40.2%), and CdLS is
associated with higher rates of self-injury than AS
(70.3% > 45.1%) [24].
Methods
Recruitment
Participants with PTHS were recruited via the Pitt
Hopkins UK family support group. All families who had
provided consent to be contacted by the syndrome
support group were invited to take part in the present
study via research advertisements shared by email and
social media platforms. Twenty-four families responded
to this invitation and provided consent to participate in
the present study.
Procedure
Parents/caregivers of individuals with PTHS were invited
to complete online questionnaires, using LimeSurvey 2.00+
software. The online survey contained information sheets,
consent forms, a background information questionnaire
including demographic questions and questions about the
person’s diagnosis and genetic mutation and informant-re-
port questionnaires assessing behavioural, psychological,
social and physical characteristics commonly reported in
ID populations.
Participants
All participants had a diagnosis of PTHS, made by a clin-
ical geneticist, paediatrician, or via medical research par-
ticipation. Reported genetic mutations were 11 unspecified
Table 1 The genetic mechanism, estimated prevalence and suggested behavioural phenotypes of the comparison syndrome
groups AS and CdLS
Syndrome Genetic mechanisms Estimated prevalence Behavioural phenotype
Pitt-Hopkins
syndrome
(PTHS)
Deletion of or variants in the TCF4 gene located at
18q21.2 that encodes transcription factor 4 [5].
Estimated as 1 in 225,
000 to 300,000 [5].
ID, speech and language impairment, anxiety, self-
injurious behaviour, aggression, repetitive behaviour
and ASD [4–7].
Angelman
syndrome
(AS)
Deficiency or disruption to the UBE3A gene located
on chromosome 15. Approximately 70% of AS cases
are caused by de novo maternal deletions at 15q11-
q13 [42].
Estimated at 1 in 20,
000 in the population
[43].
Severe ID, speech, and language impairment, ataxic
movement/movement or balance disorder (e.g.
hypermotoric behaviour), enhanced laughter/smiling,
happy demeanour, short attention spans and
aggression [12].
Cornelia de
Lange
syndrome
(CdLS)
Heterozygous mutation of the NIPBL gene, located on
chromosome 5p13 (approximately 65% of cases, with
further cases being due to mosaicism). Less
commonly caused by mutations in SMC3, SMC1A,
HDAC8 and RED21 genes (11% of cases) [44].
Estimated between 1
in 10,000 and 1 in 30,
000 live births [45].
ID, speech and language delay, self-injurious
behaviour, autistic features, repetitive behaviours,
aggression and hyperactivity [25, 36, 40, 41, 46].
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mutations of TCF4, nine deletions, one frameshift mu-
tation, one translocation, one sequence repetition and
one splice site mutation, ascertained through parent-re-
port of syndrome diagnosis details (including the
genetic mechanism if known, date of diagnosis and
diagnostic information).
The mean age of the PTHS group was 11.2 years (SD =
7.8 years, range = 1–30 years) and 50% of the sample
were male (n = 12). Eleven participants (45.8%) were fully
mobile (defined as able to walk unaided), and two partic-
ipants (8.3%) were verbal (defined as able to speak or
sign more than 30 words). Nine participants (37.5%) had
normal vision, 14 (58.3%) had poor vision and one par-
ticipant (4.2%) was blind/almost blind. Twenty-three
participants (95.8%) had normal hearing and one partici-
pant (4.2%) was deaf/almost deaf.
The comparison groups had previously participated in
research projects at the Cerebra Centre for Neurodeve-
lopmental Disorders, University of Birmingham, and had
provided consent for their data to be utilised in future
research studies. Individuals with CdLS and AS were
matched to individuals with PTHS first by level of abil-
ity, according to the self-help subscale of the Wessex
scale [52] (self-help score +/− 1 point), then by age (+/−
3 years), verbal ability (verbal or non-verbal), mobility
and sex. Every participant with PTHS but one was
matched with equal scores for ability to individuals with
AS and CdLS [52]. The age of participants was then
prioritised before matching for verbal ability, mobility
and sex.
Measures
The background information questionnaire provided de-
tails relating to sex, age, verbal ability, mobility and any
health problems encountered within the last 6 months.
Additional parent-report questionnaires included the
Wessex Questionnaire (WQ) [52], Social Communication
Questionnaire Lifetime Version (SCQ) [53], the Sociability
Questionnaire for people with Intellectual Disability
(SQID) [31], the Challenging Behaviour Questionnaire
(CBQ) [36], the Mood, Interest and Pleasure Question-
naire-Short Form (MIPQ) [32], the Repetitive Behaviour
Questionnaire (RBQ) [33], the Activity Questionnaire
(TAQ) [54], Health Questionnaire (HQ) [55], and the
Sensory Experience Questionnaire (SEQ) [56]. See Table 2
for descriptions and psychometric properties of assess-
ments used.
Data analysis
Due to violations of assumptions of parametric tests
(including of normality and homogeneity of variance),
non-parametric tests were used throughout.
Matched group comparisons
In order to compare individuals with PTHS with
matched AS and CdLS groups, a series of Kruskal-Wallis
tests were conducted to analyse group differences in
total and subscale scores of questionnaires. Participants
under the age of 4 years were excluded from SCQ data
analysis, as this measure is not validated in children
younger than 4 years [53]. Post hoc Mann-Whitney U
analyses were conducted to identify significant differ-
ences between PTHS and matched syndrome groups
individually. Categorical data derived from the SCQ
(meeting cut-off scores for ASD; SCQ scores > 15) and
CBQ (yes/no presentation of behaviours within the
previous month) were compared between groups using
chi-square analyses and Fisher’s exact tests. Effect sizes
were calculated in concordance with guidelines for non-
parametric tests [65] and interpreted according to guide-
lines by Cohen [66].
Sociability and sensory experiences
Data for the SQID and the SEQ were not available for
matched comparison groups. The analysis was therefore
conducted in relation to previously published data. To
assess sociability, single-sample Wilcoxon tests were per-
formed to compare PTHS median scores for totals and
subscales from the SQID with median scores presented
by Moss and colleagues [31] for individuals with AS and
CdLS. To explore sensory experiences in individuals
with PTHS, SEQ median and interquartile ranges were
reported and categorised into “typical”, “at risk” and
“deficient” range according to Baranek’s [56] criterion
cut-off points based upon data for typically developing
participants.a
Alpha
The relatively large number of group comparisons used
in this study increases the likelihood of type 1 errors (in-
appropriately rejecting the null hypothesis). However,
low power due to the relatively low n increases the likeli-
hood of type 2 errors (inappropriately accepting the null
hypothesis), which may involve overlooking clinically
important group differences. Therefore, effects at p <
0.05 were reported as significant, but interpretation
should be cautious, with attention also paid to effect
sizes.
Results
Cross-syndrome comparison: demographic characteristics
There were no significant differences between groups in
adaptive ability, age, verbal ability, mobility or sex (see
Table 3), indicating individuals with PTHS were well
matched to both AS and CdLS groups. The average
score on the self-help subscale of the Wessex [52] was
low (mean 4; total scores range from 3 to 9, see Table 3),
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Table 2 Description and psychometric properties of assessments used
Assessment
[authors]
Description of assessment Scoring Psychometric properties
Wessex
Questionnaire (WQ)
[52]
The questionnaire assesses ability in
individuals with ID. The following
subscales are assessed: continence,
mobility, self-help skills, speech and
literacy. Within the current study, “self-
help” was used as a proxy measure to
assess the degree of ability.
On the self-help subscale, individuals are
rated on their ability to feed, wash and
dress themselves. For each task, they are
scored on a 3-point scale. The total self-
help score ranges from 3 to 9: total score
of 3–5 (“not able”), 6–7 (“partly able”) and
8–9 (“able”).
The scale has modest inter-rater
reliability at subscale level for both
children and adults ranging from 78%
(self-help, literacy) to 92% (mobility)
[52].
Social
Communication
Questionnaire
Lifetime Version
(SCQ) [57]
The parent-report questionnaire is used
to measure ASD symptomatology and is
a screening tool for ASD based on the
Autism Diagnostic Interview. It consists of
40 items grouped into three subscales:
communication, social interaction and
repetitive and stereotyped behaviours.
The lifetime version is completed in
regards to an individual’s full
developmental history.
The 40 items all require a yes/no
response. Total scores range from 0 to 39.
A cut-off score of > 15 indicates possible
ASD and > 22 indicates possible autism.
The cut-off point of > 15 was found to
distinguish pervasive developmental
disorder (PDD) individuals from other
diagnoses with a specificity of .80 and
a sensitivity of .96 (excluding
individuals with ID) and distinguished
individuals with autism from people
with ID with a specificity of .67 and
sensitivity of .96. The higher cut-off of
> 22 was necessary to distinguish
between autism individuals with PDD
with a specificity of .60 and a
sensitivity of .75. The scale has good
concurrent validity with the Autism
Diagnostic Interview and with the
Autism Diagnostic Observation
Schedule [57, 58]. Internal consistency
is good [19, 57].
Sociability
Questionnaire for
people with
Intellectual Disability
(SQID) [31]
The informant-based questionnaire
assesses the sociability in children and
adults and is appropriate for individuals
with ID. The questionnaire contains 25
items including 13 categories and is to
be completed regarding an individual’s
typical behaviour across social situations
with familiar and unfamiliar people and
considers the possible indication of
selective mutism.
The SQID consists of 25 items, 21 are on
a 7-point scale (e.g. items 1–17: range
from “very shy” to “very sociable”) and
four are yes/no responses. Total scores
evaluate the effect of social context on
an individual’s sociability with a familiar
or unfamiliar person. A higher score
indicates more sociability.
The scale has a satisfactory inter-rater
reliability for item level between .43
and .80 (Spearman’s coefficient > .60)
for Q1-21. Kappa values for categorical
items were .96, .44 and .51 (Q22, 24,
25). The scale also has good
concurrent validity with the Child
Sociability Rating Scale (CSRS [19])
(rs = .36 to .52; all p = .01).
Challenging
Behaviour
Questionnaire (CBQ)
[36]
Part one of the questionnaire assesses the
presence of self-injury, physical
aggression, verbal aggression, destruction
of property and stereotyped behaviour
over the course of the previous month.
Part two assesses the severity of each
type of challenging behaviour.
Part one is based on a yes/no basis. Part
two requires responses on a 4–5-point
scale (14 items). Item scores are summed
to provide an overall severity score.
Lower scores indicate less severe
behaviour.
The scale has good inter-rater reliability
(range of α = .62 to .72) [36].
Concurrent validity of the total scores
of the CBQ and the Aberrant Behavior
Checklist (ABC [59]) was good (0.56,
p < .01) [60].
The Mood, Interest
and Pleasure
Questionnaire-Short
Form (MIPQ) [32]
The informant based questionnaire is
appropriate for use for individuals with ID
and assesses two main subscales of
mood and interest and pleasure.
The short form consists of 12 items (6
items for each subscale). Items are rated
on a 5-point scale, and total scores range
between 0 and 48. A higher score
indicates positive affect and higher levels
of interest and pleasure.
The short form version of the MIPQ
has good internal consistency (α
total = .88; α Mood = .79; α Interest and
Pleasure = .87), test-retest (.97) and
inter-rater reliability (.85). Concurrent
validity between the MIPQ and the
ABC [59] ranged from medium to
strong (0.36–0.73; p < .001).
Repetitive Behaviour
Questionnaire (RBQ)
[33]
The informant-based questionnaire is
appropriate for use for children and
adults with ID and examines the
frequency of repetitive behaviours over
the last month. The scale consists of 19
items including five subscales:
stereotyped behaviour, compulsive
behaviour, insistence on sameness,
restricted preferences and repetitive
speech.
Informants rate the frequency of each
behaviour over the last month. Scores are
rated on a 5-point scale from “never” (0)
to “more than once a day” (5). A verbal
score ranges between 0 and 76 and a
nonverbal score ranges between 0 and
60 (4 items are only applicable to verbal
individuals). Behaviours occurring “once a
day” or “more than once a day” are
deemed to be of clinical importance. A
clinical cut-off is obtained if an individual
has a score of three or more on at least
one item within a subscale.
Item-level inter-rater and test-retest
reliability and validity are good
Spearman’s coefficients for inter-rater
reliability range from .46 to .80 at item-
level (73% > .60). Spearman’s
coefficients for test-retest reliability
range from .61 to .93 at item level
(52.6% > .80). The scale has good
concurrent validity and content validity
between the RBQ and the repetitive
subscale of the Autism Screening
Questionnaire (ASQ [57]) (.6; p < .001).
There is good Internal consistency at
full-scale level (α > .80) and for the
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estimating limited self-help abilities. Participants with
PTHS, AS and CdLS showed similar low ability across
skill areas including washing, dressing and feeding ability.
There were fewer individuals in the PTHS group with nor-
mal vision than in the AS group (χ2(1) = 12.16, p < .001)
and more individuals with PTHS with normal hearing
compared to the CdLS group (χ2(1) = 19.5, p < .001).
Physical health
The most frequently reported lifetime health difficulties
were gastrointestinal problems (n = 20, 83.3%), described as
moderate severity by 29.2%, with seven individuals (35%)
needing corrective treatment. Other frequent health difficul-
ties were epilepsy/seizures (n = 12, 50%), ear problems (n =
12, 50%) and skin problems (n= 11, 45.8%). See Table 4 for
details regarding health difficulties experienced by individ-
uals with PTHS.
Autism spectrum disorder
There were significant between-group differences on the
total score, Communication subscale and Reciprocal
Social Interaction subscale of the SCQ (see Table 5).
Individuals with PTHS showed significantly higher
scores than those with AS on the total SCQ (U = 73.5,
p < .001, r = .59, large effect size), the Communication
subscale (U = 55, p < .001, r = .69, large effect size) and
the Reciprocal Social Interaction subscale (U = 132,
p = .009, r = .39, medium effect size). No significant
differences were found between individuals with PTHS
and CdLS on the total SCQ or any of the subscales.
According to the SCQ, a significantly greater proportion
of individuals with PTHS (95.5%) met the cut-off score
to indicate possible ASD compared to AS (68.2%) (χ2 =
5.5 (1), p = .023), with a relative risk of 1.4 (95% CI,
1.04–1.89).
Sociability
Significant differences in sociability scores were evident,
when data from the PTHS group were compared to data
from AS and CdLS groups derived from Moss et al. [31],
using the SQID (see Table 6). Individuals with PTHS
displayed significantly lower sociability than those with
Table 2 Description and psychometric properties of assessments used (Continued)
Assessment
[authors]
Description of assessment Scoring Psychometric properties
stereotyped behaviour and compulsive
behaviour subscales (α > .70), this was
lower for restricted preferences,
repetitive speech and insistence on
sameness subscales (α = .50, .54 and
.65) [61].
The Activity
Questionnaire (TAQ)
[54]
The information-based questionnaire
assesses behaviours that indicate
overactivity and impulsivity and is
suitable for use for people with ID. The
questionnaire consists of 18 items
grouped into three subscales: over-
activity, impulsive speech and impulsivity.
The score range for over-activity is 0–36,
impulsive speech 0–24 and impulsivity 0–
24. Impulsive speech is not calculated for
individuals who are non-verbal. Items are
scored on a 5-point scale of “never/
almost never” (0) to “always/almost all of
the time” (5) to assess activity frequency.
Scores of 32 for overactivity and 24 for
impulsivity are identified as “abnormally
high” (at or above the 95th percentile).
The scale has a good item level inter-
rater reliability (mean of .56, range = .31
to.75) and test-retest reliability (mean
of .75, range = .60 to .90). Inter-rater
and test-retest reliability for subscales
and total score were above .70 [54].
Sensory Experience
Questionnaire- Short
form, Version 2.1
(SEQ) [56]
The questionnaire examines the
frequency of sensory behaviours across
sensory response patterns (Hypo-Social,
Hypo-Nonsocial, Hyper-Social and Hyper-
Nonsocial), five sensory modalities
(Tactile, Auditory, Visual, Gustatory, and
Vestibular) and across social or non-social
contexts.
The scale consists of 41 items (counting
sub-items) rated on a 5-point scale of
“almost never” (1) to “almost always” (5).
A total score is obtained and sub-scores
for sensory patterns (Hypo-
responsiveness, Hyper-Responsiveness
and Sensory Seeking), a score for each
modality and for social and non-social
contexts. A higher score is indicative of
more severe sensory symptoms.
The overall internal consistency is
α = .80 [62] and for subscales Hyper-
Responsiveness α = .73, Hypo-
Responsiveness α = .75, Sensory
Seeking α = .80, Social α = .69, Non-
Social α = .78. The test-retest reliability
is .92 (intraclass correlation coefficient)
[63]. Concurrent validity between the
SEQ and the Sensory Processing
Assessment (SPA) indicated significant
correlations between Hypo-
Responsiveness subscales and Hyper-
Responsiveness scales [64].
Health
Questionnaire (HQ)
[55]
The questionnaire looks at the presence
and subsequently the severity of 15
different health difficulties, with
subsections assessing health difficulties
over the entire lifetime and over the
course of the last month.
The scale consists of 32 items. Severity of
each reported health difficulty is rated on
a 3-point scale of never (0) to severe (3).
An overall health score is determined by
summing the total for both time periods.
A higher score indicates greater severity.
Inter-rater reliability for health
difficulties reported across the
individuals lifetime was α = 0.72 and
for those present within the last
month were α = 0.76. Internal
consistency is found to be good (α =
0.77) for the overall health score [55].
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AS on both Unfamiliar (Z = 2.88, p = .004) and Familiar
(Z = 3.95, p < .001) total scores. However, individuals
with PTHS had higher sociability scores than those with
CdLS on Unfamiliar total scores (Z = 2.92, p = .004) sug-
gesting individuals with PTHS show higher levels of so-
ciability with unfamiliar adults relative to individuals
with CdLS.
Repetitive behaviour
There were no significant differences between PTHS, AS
and CdLS groups on the RBQ total scores or any sub-
scale score (Stereotyped Behaviour, Compulsive Behav-
iour or Insistence on Sameness, see Table 7). Items on
the RBQ most frequently endorsed by individuals with
PTHS were in the Stereotyped Behaviour domain, in-
cluding object stereotypy (62.5%, all more than once a
day), body stereotypy (54.2%, all more than once a day)
and hand stereotypy (79.2%, all more than once a day).
Overall, 75% of individuals with PTHS evidenced stereo-
typed behaviour within the previous month according to
the CBQ (see Table 9).
Sensory experiences
The median scores of individuals with PTHS fell into
the “deficient” range for Hypo-Responsiveness and Social
Contexts and “at-risk” for Hyper-Responsiveness, Sensory
Seeking, and Non-Social Contexts (see Table 8), accord-
ing to Baranek’s [56] classifications based on normative
data for typically developing children. The majority of
individuals with PTHS were classified as “atypical” (de-
fined as either “at risk” or “deficient” range), in relation
to Hypo-Responsiveness (95.8%) and Social Contexts
(91.7%).
Challenging behaviour
A large proportion of the individuals with PTHS had
displayed self-injurious behaviour (70.8%) and/or phys-
ical aggression (54.2%) in the last month; property de-
struction was also reported for 37.5% of the sample (see
Table 9). A significantly greater proportion of individuals
with PTHS showed self-injurious behaviour compared to
individuals with AS (χ2 = 4.15, p = .042, RR = 1.7, 95%
CI = .99–2.91), and a significantly greater proportion of
individuals with PTHS showed physical aggression com-
pared to individuals with CdLS (χ2 = 4.27, p = .039, RR =
2.17, 95% CI = .99–4.75). Fewer people with PTHS
(37.5%) displayed destruction of property relative to AS
(54.2%) or CdLS (54.2%), although these differences did
not reach statistical significance.
Mood
Individuals with PTHS displayed significantly lower
scores than individuals with AS on the total MIPQ-S
score (U = 185.5, p = .034, r = .31, medium effect size)
and Mood subscale (U = 105, p < .001, r = .55, large effect
size). No significant differences were evident between
any of the groups on the Interest and Pleasure subscale
(see Table 7).
Table 3 Demographic characteristics and statistical analyses for participant groups: PTHS and matched AS and CdLS
Demographic characteristic PTHS,
n = 24
AS, n =
24
CdLS,
n = 24
Group comparison: chi-squared and Mann-Whitney U
Comparison χ2/U p value
Self-help scorea Mean (SD) 4.04 (.62) 4.04 (.62) 4 (.51) PTHS ≈ AS 288 1.00
Median (IQR) 4 (0) 4 (0) 4 (0) PTHS ≈ CdLS 287 .967
Range 3–6 3–6 3–5
Age Mean (SD) 11.2 (7.8) 10.9 (7.3) 11.3 (7.7) PTHS ≈ AS 282 .901
Median (IQR) 8.5 (11) 8.5 (11) 9 (11) PTHS ≈ CdLS 285 .951
Range 1–30 2–27 1–30
Verbal (able to speak more than 30 signs/words) (%) 2 (8.3) 0 (0) 1 (4.2) PTHS ≈ AS 2.09 .490b
PTHS ≈ CdLS .356 1.00b
Mobile (able to walk unaided) (%) 11 (45.8) 11 (45.8) 16 (66.7) PTHS ≈ AS .000 1.00
PTHS ≈ CdLS 2.12 .146
% male 50 47.8 41.7 PTHS ≈ AS .020 .880
PTHS ≈ CdLS .336 .560
Visiona (categorised as “normal vision”) 9 (37.5) 20 (87) 14 (60.9) PTHS < AS 12.16 < .001
PTHS ≈ CdLS 2.57 .109
Hearinga (categorised as “normal hearing”) 23 (95.8) 24 (100) 8 (34.8) PTHS ≈ AS 1.02 1.00b
PTHS > CdLS 19.50 < .001
IQR interquartile range
aDerived from the Wessex Scale [52]
bFishers exact p value reported as 50% had an expected count < 5
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Activity
No significant differences were found between individ-
uals with PTHS and individuals with AS or CdLS on the
total TAQ score or Impulsivity or Overactivity subscales
(see Table 7).
Discussion
The current study used standardised informant report
measures validated for people with ID and a cross-syn-
drome comparative approach, to further understand the
behavioural profile in PTHS. To our knowledge, this is
the first study using such methodology to explore the
behavioural phenotype of PTHS.
The findings presented here are consistent with previ-
ous indications that a large majority of people with
PTHS may meet criteria for ASD [14]. A very high pro-
portion of individuals with PTHS in the current study
(> 95%) met cut-off for ASD symptomatology on the
SCQ. This significantly exceeded the proportion of indi-
viduals meeting cut-off in the group of matched individ-
uals with AS, a syndrome associated with elevated
likelihood of ASD [17]. Although a greater proportion of
individuals with PTHS than CdLS met cut-off for ASD,
Table 4 Health difficulties experienced by individuals with Pitt-Hopkins syndrome as taken from the Health Questionnaire
Never/no Mild Moderate Severe Corrective
surgery/
treatment/
medication?
N (%) N (%) N (%) N (%) N (%)
Eye problems Lifetime 17 (70.8) 2 (8.3) 3 (12.5) 2 (8.3) 5 (71.4)
Last month 23 (95.8) 1 (4.2) – –
Ear problems Lifetime 12 (50) 8 (33.3) 3 (12.5) 1 (4.2) 4 (33.3)
Last month 23 (95.8) – 1 (4.2) –
Dental problems Lifetime 20 (83.3) 1 (4.2) 2 (8.3) 1 (4.2) 1 (25)
Last month 23 (95.8) 1 (4.2) – –
Cleft palate Lifetime 24 (100) – – – –
Last month 23 (95.8) 1 (4.2) – –
Gastrointestinal problems Lifetime 4 (16.7) 9 (37.5) 7 (29.2) 4 (16.7) 7 (35)
Last month 11 (45.8) 9 (37.5) 3 (12.5) 1 (4.2)
Bowel problems Lifetime 5 (20.8) 14 (58.3) 2 (8.3) 3 (12.5) 3 (15.8)
Last month 13 (54.2) 7 (29.2) 3 (12.5) 1 (4.2)
Heart abnormalities or
circulatory problems
Lifetime 22 (91.7) 1 (4.2) 1 (4.2) – –
Last month 24 (100) – – –
Problems with genitalia Lifetime 21 (87.5) 1 (4.2) 2 (8.3) – 2 (66.7)
Last month 24 (100) – – –
Hernia Lifetime 23 (95.8) – – 1 (4.2) 1 (100)
Last month 23 (95.8) 1 (4.2) – –
Limb abnormalities Lifetime 24 (100) – – – –
Last month 24 (100) – – –
Epilepsy/seizures Lifetime 12 (50) 8 (33.3) 4 (16.7) – 5 (41.7)
Last month 20 (83.3) 2 (8.3) 2 (8.3) –
Lung or respiratory problems Lifetime 20 (83.3) 3 (12.5) 1 (4.2) – 3 (75)
Last month 24 (100) – – –
Liver or kidney problems Lifetime 24 (100) – – – –
Last month 24 (100) – – –
Diabetes or thyroid function
problems
Lifetime 24 (100) – – – –
Last month 24 (100) – – –
Skin problems Lifetime 13 (54.2) 7 (29.2) 3 (12.5) 1 (4.2) 5 (45.5)
Last month 16 (66.7) 4 (16.7) 4 (16.7) –
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this difference was not statistically significant. Notably,
CdLS is a syndrome group with a well-established asso-
ciation with ASD [17], and therefore, this finding is
consistent with high levels of ASD symptomatology in
both groups. It is important to note that the SCQ is not
a diagnostic tool and may over-estimate the prevalence
of ASD in genetic syndrome groups, given that develop-
mental level is not taken into account [20]. However,
this is likely to be the case for all syndrome groups in
the current analysis, given that their ability levels were
approximately matched. Although the SCQ has a strong
history in the elucidation of ASD-related behaviours in
genetic syndrome groups associated with divergent ID
profiles (e.g. [34, 67]), future studies should consider the
use of additional measures to explore ASD phenomen-
ology more comprehensively in PTHS.
Refining the ASD-related behavioural profile in PTHS
based on the preliminary data we have presented here
may have significant clinical implications regarding the
utility of services for ASD in this syndrome group. ASD
specific interventions may be useful for those diagnosed
with co-occurring ASD, but the specific target of such in-
terventions and their appropriateness in PTHS warrants
further investigation. Future research may wish to explore
the utility of ASD intervention models in this syndrome
group (e.g. Applied Behaviour Analysis [68]) and whether
existing ASD early intervention programs will also be of
benefit in PTHS (e.g. JASPER, Joint Attention Symbolic
Play Engagement and Regulation [69]).
It is important to consider the specific profile of ASD
phenomenology in syndrome groups, as evidence sug-
gests the profile of ASD-related behaviours may differ
from idiopathic ASD (e.g. [70]) and may also vary con-
siderably between syndrome groups (e.g. [16, 17]). In the
case of fragile X syndrome, for instance, the pattern of
repetitive behaviours (e.g. fewer compulsive and ritualis-
tic behaviours) and social communication deficits (e.g.
relatively intact social response, facial expression and so-
cial smile behaviours) appears to be qualitatively distinct
from idiopathic ASD [71], alluding more to difficulties
relating to social anxiety as opposed to social preference
[72]. Behavioural comparisons to an idiopathic ASD
group will further elucidate the profile of similarities and
differences in PTHS.
The current data suggest difficulties with both social
communication and restricted/repetitive behaviours in
PTHS, supporting earlier literature presented by Zollino
and colleagues [5]. Specifically, individuals with PTHS
showed greater social communication deficits than those
with AS and similarly high levels of impairment to those
with CdLS (as outlined in the existing CdLS literature
[19]). Further exploration of social characteristics using
a dedicated sociability questionnaire, the SQID [31],
confirmed lower levels of sociability in PTHS than in
AS, but higher sociability with unfamiliar people in
PTHS compared to CdLS. This may partially reflect high
rates of social anxiety in CdLS [50, 51] that is more
likely to manifest with unfamiliar people and potentially
Table 5 Median and interquartile ranges of ASD-related behaviours and percentage meeting criteria for ASD from the SCQ for
participant groups: PTHS, AS and CdLS
PTHS AS CdLS Kruskal-Wallis tests/
chi-squared test
Post hoc comparison: Mann-Whitney U test/chi-squared test
h/χ2 df p value Comparison U/χ2 df Z p value Effect size r/relative
risk (95% CI)
SCQ—total N 22 22 18
Median 24 18 25 18.41 2 < .001 PTHS > AS 73.50 1 3.965 < .001 0.59 (large)
IQR 3.75 7 7.57
SCQ—communication N 22 22 18
Median 8 6 6.93 25.70 2 < .001 PTHS > AS 55.00 1 4.555 < .001 0.69 (large)
IQR 0.25 3 1.25
SCQ—restricted,
repetitive and
stereotyped behaviours
N 22 22 22
Median 4 4 5 3.56 2 .169 N/A
IQR 3 2.25 2.63
SCQ—reciprocal social
interaction
N 22 22 18
Median 10.5 7 12 11.15 2 .004 PTHS > AS 132.00 1 2.598 .009 .39 (medium)
IQR 4.25 5.25 5.25
Met ASD cut-off N 22 22 18
N (%) 21 (95.5) 15 (68.2) 16 (88.9) 5.85 2 .049a PTHS > AS 5.50 1 – .023 1.40 (1.04 to 1.89)b
aFishers exact p value reported as 50% had an expected count < 5
bRelative risk of meeting criteria for ASD in AS relative to PTHS
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an absence of such social anxiety presentations in PTHS.
However, the current study also found individuals with
PTHS displayed lower mood than individuals with AS,
partially contradicting the comparable happy demeanour
and affectionate temperament in PTHS. Therefore, the
association between internalising states and social char-
acteristics warrants further investigation in PTHS.
Repetitive behaviours were comparable across all three
syndrome groups in the current study. Most notably, rates
of compulsive behaviour and insistence on sameness were
markedly low in these groups, as previously reported in
the AS and CdLS literature [61]. Specifically, a large pro-
portion of the PTHS group (75%) showed object, body or
hand stereotypies within the stereotyped behaviour do-
main, which are likely to contribute to the presentation of
ASD-like characteristics in this group. Over 95% of the
sample was reported to have displayed hypo-responsive
behaviours within social contexts and over 60% displayed
hyper-responsive behaviours to sensory input. Both hyper-
and hypo-responsivity have previously been reported in
children with ASD and developmental delay [35, 73], and
therefore, this atypical presentation of sensory processing
in individuals with PTHS may also relate to the ASD pres-
entation in this syndrome. Given the established
relationship between sensory processing deficits and ste-
reotyped behaviours in the ASD literature [74], which may
be mediated by anxiety in some cases [75], the distinct
profile of stereotyped behaviours and its potential neuro-
psychological correlates should form a focus for future
PTHS research.
High rates of physical aggression and self-injury in the
PTHS group should also be explored at a functional
level. Further research may aim to delineate potentially
contributory factors to these behaviours, in relation to
cognitive, biological and environmental correlates. It is
possible, for example, that the sensory processing diffi-
culties documented in this study may contribute to
physical aggression (e.g. see [76]), and given the estab-
lished relationship between self-injury and gastroesopha-
geal reflux in CdLS [77], the potential contribution of
pain to challenging behaviour in PTHS should not be
underestimated. A majority of participants in the current
cohort were reported to show gastrointestinal problems
(83.3%), lending support for a more thorough and
comprehensive behavioural assessment of pain in this
syndrome group. Measures such as the Face, Legs, Ac-
tivity, Cry and Consolability (FLACC) behavioural pain
assessment scale [78] and the Non-Communicating
Table 6 Median and interquartile range for PTHS and comparison syndrome groups: AS and CdLS, derived from [31] and one-
sample Wilcoxon test
Median scores PTHS (n =
24)
AS
(n = 66)
[31]
CdLS
(n = 98)
[31]
One-sample Wilcoxon test
Comparison
group [31]
Z p value PTHS significance Effect size r
SQID familiar—total Median (IQR) 42.5 (15.25) 53 (48–55) 41.5 (35–48) AS 3.95 < .001 PTHS < AS .57 (large)
CdLS .360
SQID familiar—receive
interaction
Median (IQR) 11.5 (3) 13 (12–14) 10 (8.75–12) AS 3.21 .001 PTHS < AS .46 (medium)
CdLS 2.98 .003 PTHS > CdLS .43 (medium)
SQID familiar—interaction Median (IQR) 12 (4) 13.5 (12–14) 11 (10–13) AS 2.90 .004 PTHS < AS .42 (medium)
CdLS .072
SQID familiar—approach
or initiate interaction
Median (IQR) 8 (5) 13 (10–14) 10 (7–12) AS 4.21 < .001 PTHS < AS .61 (large)
CdLS 2.47 .014 PTHS < CdLS .36 (medium)
SQID familiar—performance Median (IQR) 12 (3) 14 (12–14) 11 (9–13) AS 3.83 < .001 PTHS < AS .55 (large)
CdLS .528
SQID unfamiliar—total Median (IQR) 35.5 (12.75) 41 (31–48) 26 (13.5–35) AS 2.88 .004 PTHS < AS .42 (medium)
CdLS 2.92 .004 PTHS > CdLS .42 (medium)
SQID unfamiliar—receive
interaction
Median (IQR) 9 (3) 10 (8–12) 6.5 (3–8) AS .108
CdLS 3.30 .001 PTHS > CdLS .48 (medium)
SQID unfamiliar—interaction Median (IQR) 9.5 (3) 11 (9–12) 7 (3–9) AS 3.03 .002 PTHS < AS .44 (medium)
CdLS 2.95 .003 PTHS > CdLS .43 (medium)
SQID unfamiliar—approach
or initiate interaction
Median (IQR) 6 (4.75) 10 (6.75–12) 5 (4–7.5) AS 3.72 < .001 PTHS < AS .54 (large)
CdLS 2.33 .020 PTHS > CdLS .34 (medium)
SQID unfamiliar—performance Median (IQR) 10 (3) 10 (7–13) 7 (2.75–9) AS .203
CdLS 2.16 .031 PTHS > CdLS .31 (medium)
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Children’s Pain Checklist (NCCPC [79]) have been uti-
lised effectively to explore the relationship between pain
and behaviour in other syndrome groups (e.g. [80]) and
may offer similar utility in PTHS.
This study employed a number of measures with
known psychometric properties in ID research (e.g. [18,
19, 24, 31, 35]). However, the limitations associated with
the use of informant-report behavioural questionnaires
and a screening measure to explore ASD phenomen-
ology should be held in mind. Future research would
benefit from use of direct observational approaches and
gold standard assessment tools, such as the Autism
Diagnostic Observation Schedule (ADOS [81]) to ex-
plore specific topographies of behaviour in this syn-
drome group. More detailed measures of ability would
also enable a more thorough matching strategy, to fur-
ther delineate the contribution of ID, verbal ability and
adaptive functioning to behaviour in PTHS.
Although the AS and CdLS groups are relatively repre-
sentative of their syndromes described within literature
Table 7 Median and interquartile ranges of behavioural characteristics, Kruskal-Wallis tests and post hoc Mann-Whitney U test
analyses for participant groups: PTHS, AS and CdLS
PTHS AS CdLS Kruskal-Wallis tests Post hoc comparison: Mann-Whitney U test
h df p value Comparison U df Z p value Effect size r
CBQ—Severity N 17 10 19
Median 8 7 7 1.84 2 .4 N/A
IQR 3 3.75 3
MIPQ—Mood N 24 24 24
Median 19 22 18 24.89 2 < .001 PTHS < AS 105 1 3.819 < .001 .55 (large)
IQR 3.75 1 4.75
MIPQ—Interest and Pleasure N 24 24 24
Median 17 17.5 15 2.07 2 .356 N/A
IQR 4.75 5.5 4.75
MIPQ—Total N 24 24 24
Median 36 39.5 34 9.87 2 .007 PTHS < AS 185.5 1 2.121 .034 .31 (medium)
IQR 3.75 7 8.75
RBQ—Total N 22 23 22
Median 12 12 16.5 4.34 2 .114 N/A
IQR 6.5 10 24
RBQ—Stereotyped Behaviour N 24 23 24
Median 10.5 8 9.5 2.85 2 .241 N/A
IQR 4.5 8 6
RBQ—Compulsive Behaviour N 24 23 24
Median 0 0 0 4.23 2 .121 N/A
IQR 0 1 9.75
RBQ—Insistence on Sameness N 24 24 23
Median 0 0 0 1.39 2 .499 N/A
IQR 3 1 6
TAQ—Impulsivity N 24 24 23
Median 15.5 18 15 .552 2 .759 N/A
IQR 9.75 13.5 11
TAQ—Overactivity N 24 24 23
Median 18 19.5 19 .618 2 .734 N/A
IQR 8.75 14 13
TAQ—Total N 24 24 23
Median 33.75 35 32.5 .347 2 .841 N/A
IQR 15.25 22.9 25.8
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(e.g. [12, 24, 25]), it should be noted that the matching
process employed introduced selection bias for the com-
parison groups in this study, and thus, the AS and CdLS
groups selected may not be wholly representative. The
proportion of people meeting criteria for ASD in these
groups exceeded that generally reported in the literature
(43% CdLS, 34% AS) [17], which may be a consequence of
individuals with lower levels of adaptive functioning being
selected as matched participants for the PTHS group.
This study also did not employ direct genetic testing.
All participants had a confirmed genetic mutation of the
TCF4 gene as reported by parents/caregivers; however, it
was not possible to delineate potential genotype-pheno-
type relationships. Results indicate possible behavioural
differences between PTHS and AS groups, despite
phenotypic similarities noted in the literature; this may
be useful in distinguishing clinically between these syn-
dromes and in appropriate targeting of diagnostic tests.
Genetic analysis of both AS and PTHS can be complex,
as a number of pathogenic variants involving the UBE3A
gene and the TCF4 gene can lead to an AS or PTHS
diagnosis, respectively [4, 39]. Routine sequencing or
microarray analysis may not always be able to confirm
diagnosis and further testing, for example testing for sin-
gle exon deletions, might only be pursued if there is a
strong clinical suspicion of either of these disorders, with
behavioural features being one of the major distinguish-
ing features. Given the deletion/non-deletion phenotypic
distinctions in AS [82, 83], phenotypic differences relat-
ing to genetic subtype may be an important avenue for
future PTHS research.
Conclusion
Individuals with PTHS showed greater impairment in
reciprocal social interaction and social communication
than those with AS, with a greater proportion of those
with PTHS than AS meeting cut-off scores for ASD
symptomatology. Individuals with PTHS also evidenced
high rates of stereotyped behaviour and atypical sensory
processing, which may be further indicative of a profile
of behaviour in PTHS which has features in common
with ASD (see also [5, 14]). Future research should ex-
plore whether the profile of ASD-related characteristics
is qualitatively convergent with that of individuals with
idiopathic ASD via formal comparisons utilising direct
behavioural observations and gold standard assessments.
Table 8 Number and percentage of individuals with PTHS
scoring within the atypical range on the SEQ
N (%) within atypical range PTHS, N = 24
Total SEQ Median (IQR) 86.5 (15.98)
N (%) 23 (95.80)
Classification At risk
Hypo-responsiveness Median (IQR) 16.5 (6.25)
N (%) 23 (95.80)
Classification Deficient
Hyper-responsiveness Median (IQR) 31.2 (11.58)
N (%) 15 (62.50)
Classification At risk
Sensory-seeking Median (IQR) 42 (5.75)
N (%) 18 (75)
Classification At risk
Social contexts Median (IQR) 23.5 (7.25)
N (%) 22 (91.70)
Classification Deficient
Non-social contexts Median (IQR) 61.3 (11.50)
N (%) 18 (75)
Classification At risk
Criterion cut-off points based on typically developing normative data [56]
Total: typical range (33–74), at risk range (75–86) and deficient range (87–165).
Hypo-responsitivity: typical range (6–10), at risk range (11–12) and deficient
range (13–30). Hyper-responsitivity: typical range (14–29), at risk range (30–34)
and deficient range (35–70). Sensory seeking: typical range (13–38), at risk
range (39–47) and deficient range (48–65). Social contexts: typical range (10–
18), at risk range (19–21) and deficient range (22–50). Non-social contexts:
typical range (22–55), at risk range (56–65) and deficient range (66–11)
Table 9 Number and percentage of individuals with PTHS and matched AS and CdLS displaying challenging behaviour and chi-
squared analysis
PTHS,
N = 24
AS,
N = 24
CdLS,
N = 24
Chi-squared test Post hoc comparison: chi-squared test
χ2 df p value Comparison χ2 df p value Relative risk
(95% CI)
Displayed SIB in the last month (%) 17 (70.8%) 10 (41.7%) 19 (79.2%) 8.07 2 .018 PTHS > AS 4.15 1 .042 1.70 (.99 to 2.91)a
Displayed destruction of property
in the last month (%)
9 (37.5%) 13 (54.2%) 13 (54.2%) 1.78 2 .411
Displayed physical aggression in the
last month (%)
13 (54.2%) 16 (66.7%) 6 (25%) 8.79 2 .012 PTHS > CdLS 4.27 1 .039 2.17 (.99 to 4.75)b
Displayed stereotyped behaviour in
the last month (%)
18 (75%) 16 (66.7%) 21 (87.5%) 2.93 2 .232
aRelative risk of self-injurious behaviour in AS relative to PTHS
bRelative risk of physical aggression in CdLS relative to PTHS
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